Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-05-28Clinical Trial Update: Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular Carcinoma [NA]
Clinical trial update noting an active-not-recruiting trial evaluating the value of laparoscopic management for resectable hepatocellular ca…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: TACE Plus Ivonescimab for Unresectable Non-Metastatic HCC [Phase 1]
Phase 1 clinical trial update for TACE plus Ivonescimab in unresectable non-metastatic hepatocellular carcinoma; the study status is Not Yet…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
A clinical trials.gov update notes a recruiting study evaluating on-treatment surveillance of tumor evolution and response to systemic thera…
-
CLINICAL_TRIALS withdrawal · 2025-05-23Clinical Trial Update: Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC [Phase 2]
Phase 2 trial evaluating cadonilimab plus lenvatinib as second-line treatment for unresectable hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial from Zhejiang Cancer Hospital is investigating the combination of hepatic arterial infusion chemotherapy and immu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC [Phase 2]
Phase II trial evaluating concurrent nivolumab with external beam radiation therapy in advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC [Phase 2]
This update describes a Phase II trial comparing AK104 in combination with lenvatinib versus lenvatinib alone for second-line hepatocellular…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Evaluating Novel Therapies in ctDNA Positive GI Cancers [Phase 3]
Georgetown University is conducting a Phase 3 trial evaluating novel therapies for ctDNA-positive gastrointestinal cancers, currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Domvanalimab and Zimberelimab in Advanced Liver Cancers [Phase 2]
Phase 2 trial update examining domvanalimab and zimberelimab in advanced liver cancers, including cholangiocarcinoma and hepatocellular carc…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma [NA]
A clinical trial is evaluating adjuvant stereotactic body radiation therapy after trans-arterial chemoembolization for unresectable hepatoce…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC
Clinical trial results report the efficacy of combining Target immunotherapy with XELOX chemotherapy in advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation
A completed clinical trial evaluated whether PET/CT improves assessment of hepatocellular carcinoma after radiofrequency ablation.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer
A multicenter registry study led by Fudan University to evaluate unresectable stage III hepatocellular carcinoma (CNLC) in liver cancer. The…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere [Phase 3]
A Phase 3 clinical trial in China is evaluating the efficacy, response, and safety of TareSphere for unresectable hepatocellular carcinoma a…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery [NA]
An update on a clinical trial comparing endhole versus pressure-modulated Lipiodol delivery for hepatocellular carcinoma and neuroendocrine …
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis [NA]
A completed clinical trial evaluating contrast-enhanced ultrasound imaging for diagnosing hepatocellular carcinoma in patients with liver ci…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: FGF19 Overexpression Combination Unified Study in HCC-19 [Phase 2]
Phase 2 clinical trial investigating a FGF19 overexpression combination for hepatocellular carcinoma, currently recruiting. Sponsor: RenJi H…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC [NA]
This is a clinical trial update on QY-1-T for HBV-associated advanced hepatocellular carcinoma, with the study currently recruiting to evalu…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Ate-Bev Early Response Prediction Model in Advanced HCC
This clinical trial update outlines a study to develop an early response prediction model for advanced hepatocellular carcinoma treated with…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma
This clinical trial evaluates a proteome multimarker panel using multiple reaction monitoring as a surveillance tool for hepatocellular carc…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating SHR-8068 plus adebrelimab and bevacizumab versus sintilimab plus bevacizumab for advanced hepatocellular…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: The Dragon PLC Trial (DRAGON-PLC) [NA]
A registered clinical trial (DRAGON-PLC) sponsored by Maastricht University is currently recruiting for primary liver cancer indications inc…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Alternative Surveillance Program for Patients With High Risk Group of HCC [NA]
Clinical trial update describes an alternative surveillance program for high-risk hepatocellular carcinoma patients; the study is currently …
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib [Phase 2]
This Phase 2 clinical trial is evaluating Cadonilimab plus Regorafenib in patients with hepatocellular carcinoma who failed Camrelizumab plu…
-
CLINICAL_TRIALS other · 2025-05-15Clinical Trial Update: Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial) [Phase 2]
A Phase 2 clinical trial (SEVERANCE) is evaluating adjuvant everolimus in patients with high-risk hepatocellular carcinoma after curative re…